All about PARP inhibitors with Jo Stanford and Dr Jon Krell

Tune into this conversation with Consultant Medical Oncologist at Imperial College London, Dr. Jon Krell, and our former Cancer Prevention Officer Jo Stanford. 

The pair discuss targeted cancer drug PARP inhibitors sharing how they work, their benefits, and who might be eligible to take them.